European phase II study of mogamulizumab, an anti-CCR4 monoclonal antibody, in relapsed/refractory peripheral T-cell lymphomaPier Luigi Zinzani, F. Morschhauser, Martine E.D. Chamuleau et al.|Haematologica|2016Cited by 48